The Wellcome Trust plays a key role in supporting bio-medical research and initiatives, providing £800 million in funding a year. Susan Freeman speaks to Peter Pereira Gray, Chief Executive Officer of the Investment Division of this organisation about his approach to their investment portfolio, and their response to the COVID 19 crisis.
